Drugmaker Novo Nordisk’s third-quarter operating profit slightly lags forecast
Novo Nordisk posted third-quarter operating profit a touch below expectations on Friday but nudged up its sales outlook for this year on the back of its new drugs for type 2 diabetes and obesity.